Adverse Event Management

Latest News

With New Bispecific Antibodies in Multiple Myeloma, Nurses Need To Know How to Manage CRS
With New Bispecific Antibodies in Multiple Myeloma, Nurses Need To Know How to Manage CRS

September 8th 2023

Elizabeth Aronson, MSN, FNP-BCN, OCN, discusses how the recent approvals of elranatamab and talquetamab are changing the treatment landscape for patients with multiple myeloma.

blood cells
Black Patients With Multiple Myeloma May Require Additional Peripheral Neuropathy Monitoring When Receiving Bortezomib

August 29th 2023

Recognizing the Symptoms of Cancer-Related Cognitive Impairment
Recognizing the Symptoms of Cancer-Related Cognitive Impairment

August 18th 2023

oncology drug crash course
Oncology Drug Crash Course: Teclistamab-cqyv (Tecvayli)

August 11th 2023

breast cancer
Patricia Jakel Discusses Challenges for Patients with Breast Cancer Taking Novel Therapies

August 9th 2023

Video Interviews
Podcasts
Bringing a New Approach to Symptom Management in Ovarian Cancer
The Vitals - Oncology Nursing News
Latest CME Events & Activities

Reflective Case-Based Oncology Collective: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Catching Them Early: A Real-World Case Discussion on the Application of Testing Methodologies to Identify Key Markers Across NSCLC

View More

20th Annual Meeting of the International Society of Gastrointestinal Oncology®

Register Now!

5th Annual Precision Medicine Symposium: An Illustrated Tumor Board

Register Now!

2022 BURST Year in Review™: Reflecting on Recent Evidence for Testing in Patients with GI Cancers

View More

2nd Annual International Congress on Pediatric Oncology

View More

2022 BURST Year in Review™: How Has Recent Evidence in Testing Elevated Outcomes in Patients with Lung Cancers

View More

Expanding Options Beyond Conventional Therapy in HR+ Breast Cancer to Overcome Unmet Needs

View More

Community Practice Connections™: 23rd Annual International Lung Cancer Congress®

View More

21st Annual School of Breast Oncology

Register Now!

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow®

Register Now!

18th Annual New York Lung Cancers Symposium®

Register Now!

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

View More

Medical Crossfire: How Should We Leverage Multidisciplinary Lung Cancer Care Teams in Managing Earlier Forms of NSCLC... When the Goal Is Cure?

View More

Medical Crossfire®: Multidisciplinary Strategies to Leverage Clinical Advances on Immune-Based Therapies for Patients with Hepatocellular Carcinoma

View More

Advancing Precision Care Through Biomarker-Driven Therapy: CEACAM5 as a Therapeutic Target in NSCLC

View More

Community Practice Connections™: 19th Annual Meeting of the International Society of Gastrointestinal Oncology®

View More

Community Practice Connections™: Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers

View More

2nd Annual Virtual Tumor Board®: Integrating Emerging Testing Methodologies into Optimal Treatment Planning in Gastrointestinal Cancers

View More

How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities

Register Now!

PER's Breast Cancer Symposia in San Antonio

Register Now!

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

Burst CME™ - Part III – Advent of HER3 Targeted Approaches and Rationale in Breast Cancer Care

View More

Burst CME™ - Part I – Overview of Pathophysiology, Diagnosis, and Management of HER3 Expressing Cancers

View More

Burst CME™ - Part II – Advent of HER3 Targeted Approaches and Rationale in NSCLC Care

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Genitourinary Malignancies from Paris

View More

Show Me Your Care Plan™: Monitoring and Managing Patients With EGFR Exon20 Insertion+ NSCLC

View More

Virtual Tumor Board®: Optimizing HER2 Testing Strategies for Clinical Decision Making in GI Malignancies

View More

Advances In™: Meeting Unmet Clinical Needs in TNBC and HR+ Breast Cancer with TROP2-Targeted Regimens

View More

Medical Crossfire®: Clinical Decision-Making Under New Paradigms for HR+/HER2- Breast Cancer

View More

More News

© 2023 MJH Life Sciences

All rights reserved.